GB0712524D0 - Novel schizophrenia associated genes - Google Patents

Novel schizophrenia associated genes

Info

Publication number
GB0712524D0
GB0712524D0 GBGB0712524.8A GB0712524A GB0712524D0 GB 0712524 D0 GB0712524 D0 GB 0712524D0 GB 0712524 A GB0712524 A GB 0712524A GB 0712524 D0 GB0712524 D0 GB 0712524D0
Authority
GB
United Kingdom
Prior art keywords
associated genes
schizophrenia associated
novel
novel schizophrenia
schizophrenia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0712524.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Priority to GBGB0712524.8A priority Critical patent/GB0712524D0/en
Publication of GB0712524D0 publication Critical patent/GB0712524D0/en
Priority to PCT/GB2008/002204 priority patent/WO2009001095A2/fr
Ceased legal-status Critical Current

Links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0712524.8A 2007-06-28 2007-06-28 Novel schizophrenia associated genes Ceased GB0712524D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0712524.8A GB0712524D0 (en) 2007-06-28 2007-06-28 Novel schizophrenia associated genes
PCT/GB2008/002204 WO2009001095A2 (fr) 2007-06-28 2008-06-26 Nouveaux gènes associés à la schizophrénie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0712524.8A GB0712524D0 (en) 2007-06-28 2007-06-28 Novel schizophrenia associated genes

Publications (1)

Publication Number Publication Date
GB0712524D0 true GB0712524D0 (en) 2007-08-08

Family

ID=38420842

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0712524.8A Ceased GB0712524D0 (en) 2007-06-28 2007-06-28 Novel schizophrenia associated genes

Country Status (2)

Country Link
GB (1) GB0712524D0 (fr)
WO (1) WO2009001095A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010029171A (ja) * 2008-06-25 2010-02-12 Srl Inc 統合失調症の診断方法
ES2562684B1 (es) * 2014-08-04 2017-02-06 Consejo Superior De Investigaciones Científicas (Csic) Método de monitorización de tratamiento antipsicótico

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001075440A2 (fr) * 2000-03-31 2001-10-11 Mitsubishi Pharma Corporation Genes associes a la schizophrenie
JP2003038198A (ja) * 2001-07-27 2003-02-12 Univ Niigata 精神分裂病により発現量が変化する遺伝子を規定する核酸を解析する方法
US20070105105A1 (en) * 2003-05-23 2007-05-10 Mount Sinai School Of Medicine Of New York University Surrogate cell gene expression signatures for evaluating the physical state of a subject
AU2004256425A1 (en) * 2003-06-09 2005-01-20 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US20080274456A1 (en) * 2004-06-09 2008-11-06 Bruce Yankner Methods and Compositions for Modifying Gene Regulation and Dna Damage in Ageing
JP2008538238A (ja) * 2005-03-31 2008-10-16 ザ・ボード・オブ・トラスティーズ・オブ・ザ・レランド・スタンフォード・ジュニア・ユニバーシティ 神経精神障害を診断および処置するための組成物および方法
US20070292880A1 (en) * 2006-05-05 2007-12-20 Robert Philibert Compositions and methods for detecting predisposition to a substance use disorder or to a mental illness or syndrome

Also Published As

Publication number Publication date
WO2009001095A3 (fr) 2009-03-26
WO2009001095A2 (fr) 2008-12-31

Similar Documents

Publication Publication Date Title
MX2011009539A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso.
IN2012DN02737A (fr)
AU2012205878A8 (en) miRNA for treating diseases and conditions associated with neo-angiogenesis
WO2009026657A8 (fr) Agonistes flavonoïdes de ppar
MX2018009945A (es) Composiciones y metodos novedosos para el tratamiento de las enfermedades relacionadas con la inmunidad.
MY158992A (en) Forms of rifaximin and uses thereof
MX2009008430A (es) Anticuerpos anti-robo4 y sus usos.
SG10201803862UA (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
MY158257A (en) Forms of rifaximin and uses thereof
AU2011274619A8 (en) miRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway
EP2576578A4 (fr) Formes polymorphiques du 2'-o-fucosyllactose et leurs procédés de production
DE602006018709D1 (de) Estergebundene geminitensidverbindungen zur verwendung in der gentherapie
MX2012004525A (es) Compuestos.
ECSP11011541A (es) Antagonistas de la trayectoria hedgehog de ftalazina disustituida
MX2015007379A (es) Nuevos compuestos.
WO2014152965A3 (fr) Loci génétiques associés à la schizophrénie identifiés dans des études d'association sur génome total et leur utilisation en tant que nouvelles cibles thérapeutiques
TW200700064A (en) Novel compounds
WO2011001135A3 (fr) Diagnostic et traitement de la maladie d'alzheimer
WO2011053901A3 (fr) Nanostructures magnetiques utilisees en tant qu'agents theranostiques
UA107204C2 (uk) Протигрибкова композиція, що містить грибковий організм pythium oligandrum
WO2008060945A3 (fr) Diagnostic et traitement du cancer du sein
MX2013004747A (es) Marcadores de gen de sangre periferica para el diagnostico temprano de la enfermedad de parkinson.
GB0803912D0 (en) Novel Uses of VEGFxxxb
GB0712524D0 (en) Novel schizophrenia associated genes
GB0508988D0 (en) Organic compounds

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application
AT Applications terminated before publication under section 16(1)